Nice (NICE) reported $786.5 million in revenue for the quarter ended December 2025, representing a year-over-year increase of 9%. EPS of $3.24 for the same period compares to $3.02 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $778.66 million, representing a surprise of +1.01%. The company delivered an EPS surprise of +0.84%, with the consensus EPS estimate being $3.21.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how th ...

Core Insights - 10x Genomics reported revenue of $166.03 million for Q4 2025, reflecting a year-over-year increase of 0.6% and a slight surprise of +0.01% over the Zacks Consensus Estimate of $166.01 million [1] - The company posted an EPS of -$0.13, which is an improvement compared to -$0.40 from the previous year, resulting in an EPS surprise of +31.58% against the consensus estimate of -$0.19 [1] Revenue Breakdown - Services revenue reached $8.47 million, exceeding the four-analyst average estimate of $7.78 million, marking a year-over-year increase of +18.7% [4] - Instruments revenue was reported at $15.47 million, surpassing the three-analyst average estimate of $14.4 million, but showing a significant year-over-year decline of -36.5% [4] - Spatial consumables revenue amounted to $40.96 million, slightly above the $39.03 million average estimate, with a year-over-year increase of +14.4% [4] - Total consumables revenue was $141.75 million, exceeding the estimated $134.78 million, representing a year-over-year growth of +6.2% [4] - Instruments revenue in the spatial category was $9.36 million, above the average estimate of $7.98 million, but reflecting a year-over-year decrease of -30.3% [4] Stock Performance - Over the past month, shares of 10x Genomics have declined by -8.5%, in contrast to the Zacks S&P 500 composite's slight decrease of -0.3% [3] - The stock currently holds a Zacks Rank 4 (Sell), indicating potential underperformance relative to the broader market in the near term [3]

Core Insights - RE/MAX reported a revenue of $73.25 million for the quarter ended September 2025, reflecting a decrease of 6.7% year-over-year, while EPS was $0.37, down from $0.38 in the same quarter last year [1] - The revenue exceeded the Zacks Consensus Estimate of $73.14 million by 0.15%, and the EPS surpassed the consensus estimate of $0.36 by 2.78% [1] Revenue Breakdown - Marketing Funds fees amounted to $18.14 million, slightly above the average estimate of $18.05 million, but down 9.7% year-over-year [4] - Continuing franchise fees were reported at $27.45 million, below the estimated $29.2 million, representing a decline of 10.9% compared to the previous year [4] - Franchise sales and other revenue reached $5.14 million, exceeding the average estimate of $4.25 million, with a year-over-year increase of 9.5% [4] - Broker fees totaled $14.9 million, surpassing the estimated $13.89 million, with a minimal decline of 0.1% year-over-year [4] - Annual dues were reported at $7.62 million, slightly below the average estimate of $7.81 million, reflecting a year-over-year decrease of 4.4% [4] Stock Performance - Over the past month, RE/MAX shares have returned -11.3%, contrasting with a +3.6% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]

Core Insights - Advanced Micro Devices (AMD) reported a revenue of $7.69 billion for the quarter ended June 2025, reflecting a year-over-year increase of 31.7% [1] - The earnings per share (EPS) for the quarter was $0.48, down from $0.69 in the same quarter last year [1] - The revenue exceeded the Zacks Consensus Estimate of $7.41 billion by 3.74%, while the EPS also surpassed the consensus estimate of $0.47 by 2.13% [1] Revenue Breakdown - Data Center revenue was $3.24 billion, slightly below the average estimate of $3.31 billion, representing a year-over-year increase of 14.3% [4] - Embedded revenue reached $824 million, slightly above the average estimate of $818.3 million, but showed a year-over-year decline of 4.3% [4] - Gaming revenue significantly increased to $1.12 billion, surpassing the estimated $750.4 million, marking a year-over-year growth of 73.2% [4] - Client revenue was reported at $2.5 billion, slightly below the average estimate of $2.53 billion, with a year-over-year increase of 67.5% [4] Stock Performance - AMD shares have returned 31.1% over the past month, outperforming the Zacks S&P 500 composite, which saw a 1% change [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the broader market in the near term [3]

Core Insights - FirstCash Holdings reported revenue of $830.62 million for the quarter ended June 2025, reflecting a slight decrease of 0.1% year-over-year, while EPS increased to $1.79 from $1.37 in the same quarter last year, indicating a positive trend in earnings despite revenue decline [1] - The revenue exceeded the Zacks Consensus Estimate of $824.3 million by 0.77%, and the EPS surpassed the consensus estimate of $1.66 by 7.83%, showcasing better-than-expected performance in earnings [1] Revenue Breakdown - Revenue from leased merchandise income was reported at $139.78 million, which is 28.2% lower than the previous year and below the average estimate of $145.87 million from two analysts [4] - Revenue from pawn loan fees reached $190.82 million, slightly above the estimated $190.61 million, marking a year-over-year increase of 5.4% [4] - Revenue from interest and fees on finance receivables was $76.08 million, exceeding the average estimate of $74.67 million, with a significant year-over-year increase of 33.9% [4] Stock Performance - Over the past month, FirstCash shares have returned -0.8%, contrasting with the Zacks S&P 500 composite's increase of 5.7%, indicating underperformance relative to the broader market [3] - The stock currently holds a Zacks Rank 4 (Sell), suggesting potential underperformance in the near term [3]